- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
-
Thursday, November 26th
Novartis Partners with U.S. Government for Faster Flu Vaccine Manufacturing
-
Sunday, November 22nd
GlaxoSmithKline Takes 'Three-Pronged' Approach in China to Fight H1N1 Flu
-
Thursday, November 19th
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
-
Monday, November 16th
Glaxo Receives Approval for Its H1N1 Vaccine
-
Monday, November 9th
Meridian: A Timely Stock to Consider
-
Sunday, November 8th
Cel-Sci, Johns Hopkins Move Forward with LEAPS
-
Friday, October 30th
Simcere Gains Majority Control of Vaccine Subsidiary
-
Wednesday, October 28th
Sinovac on Track to See Sizable Revenue from Flu Vaccines
-
Tuesday, October 27th
Cel-Sci's Targets Stay on Track
-
Friday, October 23rd
Sinovac Wins Approval for Swine Flu Vaccine in Mexico
-
Thursday, October 22nd
Hand Sanitizer Sales Double on H1N1 Panic
-
Tuesday, October 20th
Cel-Sci: Things Are Just Getting Started
-
Wednesday, October 14th
Cel-Sci: Why I'm Buying if the Price Dips
-
Wednesday, October 7th
H1N1: How to Buy into the Fear
-
Monday, October 5th
Baxter’s Swine Flu Vaccine Gets a Boost
-
Friday, October 2nd
Swine Flu Stocks: Where Are They Now?
-
Thursday, September 17th
Cel-Sci's Positive Momentum Keeps Building
-
Monday, September 7th
Novavax's VLP Technology Is a Game Changer
-
Sunday, September 6th
China Biotech in Review: The Flight to Fight Off the Flu
-
China Starts Flu Vaccine Stockpile with Sinovac Order
-
Friday, September 4th
Sinovac Wins OK to Produce H1N1 Vaccine
-
Wednesday, September 2nd
Swine Flu ETFs in Focus
-
Canada's Transat: A Play on the Rising Loonie?
-
Tuesday, September 1st
Sinovac's H1N1 Flu Vaccine Wins Experts' Recommendation